Quote:
Originally Posted by jonbxx
You are absolutely right, the best way would be to mirror EMA rules at least in the short term, creating a ‘one way single market’ for drug imports. The other way with exports may be more tricky but that wasn’t the issue being discussed here.
The major concern regarding drug shortages is holdups at the import stage, especially for cold chain drugs such as vaccines and other biologicals, hence the article from Sir Michael Rawlins, head of the MHRA- https://www.pharmaceutical-journal.c...irstPass=false |
Still not seeing anything that would explain any alleged potential blockage or hold-up.
Quote:
He said: “We can’t just sit at the edge of the room watching what’s going on, not speaking: we need to have a say.
“We do about a third of scientific assessments for the EMA, so we make a major contribution. The EMA has reassigned the UK’s portfolio of centrally authorised products to other EU member states, but the ideal solution would be to get it all back again.”
|
Any blockages or hold-ups on drugs or anything else, would be at the EU end, ie Export from the UK.